Geron Corp
NASDAQ:GERN

Watchlist Manager
Geron Corp Logo
Geron Corp
NASDAQ:GERN
Watchlist
Price: 1.33 USD 3.91% Market Closed
Market Cap: 847.1m USD

EV/OCF
Enterprise Value to OCF

-2.8
Current
-6.4
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-2.8
=
Enterprise Value
569m USD
/
Operating Cash Flow
-204.3m USD
Market Cap EV/OCF
US
Geron Corp
NASDAQ:GERN
847.1m USD -2.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -212 438.8
US
Abbvie Inc
NYSE:ABBV
335.8B USD 24.2
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD -14 474
US
Amgen Inc
NASDAQ:AMGN
165.8B USD 17.3
US
Gilead Sciences Inc
NASDAQ:GILD
141.5B USD 14.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.3B USD -119.2
US
Epizyme Inc
F:EPE
94.1B EUR -530
AU
CSL Ltd
ASX:CSL
128.6B AUD 31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.8B USD 14.3
US
Seagen Inc
F:SGT
39.3B EUR -83.2
 
US
Geron Corp
NASDAQ:GERN
Average EV/OCF: 20.4
Negative Multiple: -2.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 438.8
US
Abbvie Inc
NYSE:ABBV
24.2
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 474
US
Amgen Inc
NASDAQ:AMGN
17.3
US
Gilead Sciences Inc
NASDAQ:GILD
14.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530
AU
CSL Ltd
ASX:CSL
31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.2

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A